NeoAntigen tumor vaccine (Houchao)

N/A

Report date: 2024/12/20 09:40:54

Base Information

Drug NameNeoAntigen tumor vaccine (Houchao)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionGene transferenceImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Houchao Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Houchao Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A